ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMM Immupharma Plc

2.35
0.11 (4.91%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.11 4.91% 2.35 2.30 2.40 2.30 2.20 2.20 1,317,704 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -2.02 7.67M

Immupharma PLC Directorate Change (1938D)

23/10/2015 7:00am

UK Regulatory


TIDMIMM

RNS Number : 1938D

Immupharma PLC

23 October 2015

 
 FOR IMMEDIATE RELEASE   23 OCTOBER 2015 
 

BOARD CHANGE

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that Ajay Agrawal has stepped down as Non-Executive Director with immediate effect.

Tim McCarthy, Non-Executive Chairman said: "We would like to thank Ajay for his contribution whilst at ImmuPharma.

"In the short period of time as Chairman, I have become more convinced of our lead programme Lupuzor. This has the potential to bring success for ImmuPharma, reward our long standing shareholders and ultimately to provide a significant treatment for lupus sufferers, globally. I am delighted to be part of the team driving this strategy forward."

-Ends-

For further information please contact:

 
                                               + 44 (0) 20 
 ImmuPharma plc                                  7152 4080 
 Tim McCarthy, Chairman 
 Lisa Baderoon, Head of Investor             + 44 (0) 7721 
  Relations                                         413496 
 
 Panmure, Gordon & Co., NOMAD &            +44 (0) 20 7886 
  Broker                                              2500 
 Fred Walsh, Duncan Monteith, Corporate 
  Finance 
  Charles Leigh-Pemberton, Corporate 
  Broking 
 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAPKBDQNBDBAKB

(END) Dow Jones Newswires

October 23, 2015 02:00 ET (06:00 GMT)

1 Year Immupharma Chart

1 Year Immupharma Chart

1 Month Immupharma Chart

1 Month Immupharma Chart

Your Recent History

Delayed Upgrade Clock